Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical effect data for AMG 557 in adults with psoriasis are reported; the trial was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AMG 557

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 1 | Status: TERMINATED